KCNJ11 Gene Genetic Test for Non‑Insulin‑Dependent Diabetes Mellitus (NIDDM) in UAE | 2800 AED | DHA Licensed Lab 1143

Executive Summary & Core Metrics

Diagnostic Accuracy: 99.9% analytical sensitivity via ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139).
Specimen Logistics: VIP Mobile Phlebotomy & temperature‑controlled cold‑chain home collection available daily 8 AM – 11 PM.
Clinical Follow‑Up: Telephonic post‑test guidance provided by a DHA‑licensed genetics specialist.
Insurance & Billing: Direct billing verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The KCNJ11 genetic test analyses the full coding region of the KCNJ11 gene to identify pathogenic variants associated with non‑insulin‑dependent diabetes mellitus (NIDDM). This enables precise risk stratification, personalised lifestyle modifications, and pharmacologic intervention planning under medical supervision.

Parameter	Our Test (ISO – DHA Aligned)	Closest Alternative
Precision	99.9% analytical sensitivity / Full gene coverage	Targeted genotyping (limited SNPs)
Method	Next‑Generation Sequencing (NGS) + validated bioinformatics	Sanger sequencing of selected exons
Turnaround Time	3–4 Weeks	4–6 Weeks

Physician Insight & Safety Protocols

“This genetic assay offers a detailed view into an individual’s predisposition for non‑insulin‑dependent diabetes. Results must be interpreted alongside clinical history, family pedigree, and metabolic parameters. Any therapeutic changes should only be made under the direct supervision of the treating physician.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Advisory Notice – Medication Management

⚠️ Do Not Self‑Adjust Medications

Never discontinue, alter, or adjust prescribed diabetes medications without consulting your attending physician. This test is designed to guide long‑term management strategies, not to direct acute therapy changes.

Exclusion Criteria & Emergency Red Flags

This test is not intended for patients currently experiencing diabetic ketoacidosis or hyperosmolar hyperglycaemic state.
It does not replace standard diagnostic glucose monitoring – do not delay urgent medical care.
If you develop acute confusion, severe dehydration, rapid breathing, or loss of consciousness, proceed to the nearest emergency department immediately.

Patient FAQ & Clinical Guidance

1. What exactly does this genetic test detect?

This test identifies pathogenic mutations in the KCNJ11 gene that are linked to non‑insulin‑dependent diabetes. Complete gene sequencing reveals variants affecting insulin secretion and beta‑cell function, enabling your doctor to stratify risk and tailor prevention or treatment plans.

2. Is any preparation or fasting required before sample collection?

No fasting or medication changes are needed. A pre‑test genetic counselling session is recommended. You may provide a whole blood sample (venous draw), an extracted DNA specimen, or a dried blood spot on an FTA card without altering your daily routine.

3. How long until I receive my results?

Results are available within 3 to 4 weeks from the date of sample receipt at our ISO‑certified laboratory. The turnaround time includes NGS sequencing, comprehensive variant interpretation, and a verified report reviewed by a consultant medical geneticist.

UAE Regulatory & Data Privacy Adherence

This genetic testing service complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability. All genetic data is processed under strict confidentiality protocols.

Clinical & Logistical Metadata

Test Name	KCNJ11 Gene Genetic Test for Non‑Insulin‑Dependent Diabetes Mellitus (NIDDM)
Price (AED)	2,800 AED
Turnaround Time	3–4 Weeks
Sample Type / Matrix	Peripheral Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)
Methodology Used	Next‑Generation Sequencing (NGS) with full gene coverage and validated bioinformatics
ICD-10-CM Code	E11.9
LOINC Code	54235-8
DHA Facility License & Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE